What is Coronary Microvascular Dysfunction (CMD) at Apollo Hospitals?

CMD assessment at Apollo Hospitals is an advanced diagnostic technique using a specialized wire to evaluate the smallest blood vessels in the heart, often identifying causes of chest pain missed by routine angiograms.

Can CMD assessment help women with chest pain?

Yes, CMD assessment is particularly helpful for women experiencing chest pain even with normal angiograms, as it pinpoints microvascular issues as the cause.

How quickly does treatment for CMD work?

Following targeted treatment for CMD, patients can experience improvement within a day and may be discharged within 24 hours.

Home / Health / Heart Pain Mystery Solved: Microvascular Dysfunction Found

Heart Pain Mystery Solved: Microvascular Dysfunction Found

7 Jan

•

Summary

A 62-year-old woman's chest pain was diagnosed using advanced Coronary Microvascular Dysfunction assessment.
The specialized wire test identified issues in the heart's smallest blood vessels, missed by routine angiograms.
Targeted treatment led to rapid improvement, with the patient discharged within 24 hours.

Heart Pain Mystery Solved: Microvascular Dysfunction Found

Apollo Hospitals has successfully diagnosed and treated a complex case of angina, or chest pain caused by reduced blood flow to the heart, by employing advanced Coronary Microvascular Dysfunction (CMD) assessment. This innovative approach was crucial for a 62-year-old woman experiencing persistent chest pain, even after her angiogram results appeared normal. The specialized assessment, utilizing a unique wire, meticulously examined the heart's smallest blood vessels, uncovering the underlying cause that routine tests had failed to detect.

This breakthrough allowed for precise, targeted treatment tailored to the identified microvascular issue. The patient experienced a remarkable improvement in her condition within just one day of receiving the specialized care. This rapid recovery underscores the significant impact of advanced diagnostic techniques when initial tests do not reveal the root of cardiac symptoms. The patient was subsequently discharged within 24 hours of the intervention.